raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:44890

Gastrointestinal stromal tumor

Synonyms: GIST · Gastrointestinal stromal sarcoma

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Not applicable
Age of onset
Adolescent, Adult, Childhood
Status
active

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal (GI) tract, typically presenting in adults over the age of 40 (mean age 63), and only rarely in children, in various regions of the GI tract, most commonly the stomach or small intestine but also less commonly in the esophagus, appendix, rectum and colon. GISTs can be asymptomatic or present with various non-specific signs, depending on the location and size of tumor, such as loss of appetite, anemia, weight loss, fatigue, abdominal discomfort or fullness, nausea, vomiting, as well as an abdominal mass, blood in stool, and intestinal obstruction. GISTs can also be seen in familial syndromes such as Carney triad and neurofibromatosis type 1.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enGastrointestinal stromal tumorGIST · Gastrointestinal stromal sarcoma
frTumeur stromale gastro-intestinaleGIST · Sarcome stromal gastro-intestinal
deStroma-Tumor, gastrointestinalerGIST · Gastrointestinales Stromasarkom
esTumor del estroma gastrointestinalGIST · Sarcoma estromal gastrointestinal · Tumor estromal gastrointestinal
itTumore stromale gastrointestinaleGIST · Sarcoma stromale gastrointestinale
nlGastro-intestinale stromale tumorGIST · Gastro-intestinaal stromaal sarcoom
ptTumor gastrointestinal do estromaGIST · Sarcoma gastrointestinal do estroma
plNowotwory podścieliskowe przewodu pokarmowegoGIST · Mięsaki podścieliskowe przewodu pokarmowego
csGastrointestinální stromální tumorGIST · Gastrointestinální stromální sarkom
ukСтромальна пухлина шлунково-кишкового трактуШлунково-кишкова стромальна саркома · GIST
zh胃肠道间质肿瘤胃肠道间质肿瘤
trGastrointestinal stromal tümörGIST · Gastrointestinal stromal sarkom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM175510BTNTvalidated
OMIM606764Evalidated
ICD-10C26.9NTBTattributedvalidated
ICD-112B5BEspecificvalidated
ICD-11XH9HQ1Especificvalidated
MONDO0011719Evalidated
MeSHD046152Evalidated
UMLSC0238198Evalidated
GARD8598Evalidated
MedDRA10051066Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

7 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SDHBCandidate gene tested inNot yet assessedHGNC:10681ENSG000001171181854701p36.13succinate dehydrogenase complex iron sulfur subunit B21173220[PMID]
SDHCCandidate gene tested inNot yet assessedHGNC:10682ENSG000001432526024131q23.3succinate dehydrogenase complex subunit C21173220[PMID]
KITDisease-causing germline mutation(s) (gain of function) inAssessedHGNC:6342ENSG000001574041649204q12KIT proto-oncogene, receptor tyrosine kinase11073817[PMID]
SDHADisease-causing germline mutation(s) (loss of function) inAssessedHGNC:10680ENSG000000735786008575p15.33succinate dehydrogenase complex flavoprotein subunit A23730622[PMID]_23282968[PMID]_21505157[PMID]_21997697[PMID]
PDGFRADisease-causing germline mutation(s) inAssessedHGNC:8803ENSG000001348531734904q12platelet derived growth factor receptor alpha33737510[PMID]
KITDisease-causing somatic mutation(s) inAssessedHGNC:6342ENSG000001574041649204q12KIT proto-oncogene, receptor tyrosine kinase23730622[PMID]
PDGFRADisease-causing somatic mutation(s) inAssessedHGNC:8803ENSG000001348531734904q12platelet derived growth factor receptor alpha23730622[PMID]
5

Prevalence and incidence

8 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00013 / 100 000EuropeValue and classValidatedEuropean Medicines Agency[OTHER]_23623056[PMID]
Annual incidence1-9 / 100 0001 / 100 000EuropeValue and classNot yet validated21420965[PMID]_23623056[PMID]
Annual incidence1-9 / 100 0001 / 100 000WorldwideValue and classNot yet validated23177515[PMID]
Annual incidence1-9 / 100 0001.9 / 100 000Korea, Republic ofValue and classNot yet validated20514305[PMID]
Point prevalence1-5 / 10 00014.5 / 100 000Hong KongValue and classNot yet validated16610025[PMID]
Annual incidence1-9 / 100 0001.82 / 100 000Hong KongValue and classNot yet validated16610025[PMID]
Annual incidence1-9 / 100 0001.5 / 100 000United StatesValue and classNot yet validated11213830[PMID]_23079473[PMID]
Point prevalence1-5 / 10 00012.9 / 100 000SwedenValue and classValidated15648083[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

18 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100723Gastrointestinal stroma tumor
HP:0006753Neoplasm of the stomach
HP:0100242Sarcoma
Frequent (79-30%)
HP:0002019Constipation
HP:0002015Dysphagia
HP:0012378Fatigue
HP:0002239Gastrointestinal hemorrhage
HP:0005214Intestinal obstruction
HP:0002017Nausea and vomiting
Occasional (29-5%)
HP:0001392Abnormality of the liver
HP:0001903Anemia
HP:0100751Esophageal neoplasm
HP:0007400Irregular hyperpigmentation
HP:0100273Neoplasm of the colon
HP:0007378Neoplasm of the gastrointestinal tract
HP:0100743Neoplasm of the rectum
HP:0100833Neoplasm of the small intestine
HP:0000988Skin rash

Run the differential on the 3 obligate / very frequent terms

7

Sources for this card